Kazuya Monden

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Cancer · 2013 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease

Kazuma Nagata, Keisuke Tomii, Kojiro Otsuka et al. · Respirology · 2012 · 50 citations

Medicine, Clinical Sciences, Internal Medicine +17

Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation

Kosuke Tanaka, Akito Hata, Reiko Kaji et al. · Journal of Thoracic Oncology · 2013 · 47 citations · Full text

Medicine, Oncology, Pharmacology +12

Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma

Daichi Fujimoto, Keisuke Tomii, Takehiro Otoshi et al. · Lung Cancer · 2013 · 38 citations

Medicine, Molecular Genetics, Oncology +15

Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · PubMed · 2015 · 27 citations

Medicine, Neurology, Oncology +17